Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nuclear Medicine | 4 | 2021 | 233 | 2.320 |
Why?
|
Cardiology | 8 | 2022 | 1675 | 2.130 |
Why?
|
Heart Failure | 57 | 2023 | 11089 | 1.900 |
Why?
|
Ventricular Dysfunction, Left | 30 | 2023 | 2058 | 1.570 |
Why?
|
Laboratories | 4 | 2022 | 459 | 1.300 |
Why?
|
Myocardial Perfusion Imaging | 8 | 2023 | 548 | 1.080 |
Why?
|
Ventricular Function, Left | 27 | 2023 | 3704 | 1.070 |
Why?
|
Sarcoidosis | 7 | 2019 | 513 | 1.050 |
Why?
|
Hypertrophy, Left Ventricular | 7 | 2017 | 842 | 0.990 |
Why?
|
Stroke Volume | 31 | 2023 | 5139 | 0.840 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3055 | 0.830 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 3167 | 0.830 |
Why?
|
Pandemics | 7 | 2022 | 8434 | 0.820 |
Why?
|
Atherosclerosis | 10 | 2023 | 3417 | 0.760 |
Why?
|
Cardiovascular Diseases | 20 | 2024 | 15308 | 0.730 |
Why?
|
Cardiomyopathies | 8 | 2020 | 1897 | 0.720 |
Why?
|
Exercise Test | 13 | 2023 | 2082 | 0.720 |
Why?
|
Prediabetic State | 2 | 2015 | 523 | 0.680 |
Why?
|
Cardiac Resynchronization Therapy | 2 | 2016 | 529 | 0.670 |
Why?
|
Myocardial Infarction | 30 | 2023 | 11655 | 0.660 |
Why?
|
Laboratories, Hospital | 1 | 2020 | 193 | 0.650 |
Why?
|
Diabetes Mellitus | 8 | 2022 | 5764 | 0.650 |
Why?
|
Renal Insufficiency, Chronic | 7 | 2023 | 2190 | 0.600 |
Why?
|
Coronary Artery Disease | 12 | 2023 | 6454 | 0.600 |
Why?
|
Erythropoietin | 2 | 2012 | 720 | 0.590 |
Why?
|
Natriuretic Peptide, Brain | 8 | 2023 | 1598 | 0.570 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 9 | 2015 | 442 | 0.540 |
Why?
|
Ventricular Remodeling | 11 | 2023 | 1223 | 0.540 |
Why?
|
Practice Guidelines as Topic | 4 | 2021 | 7271 | 0.530 |
Why?
|
Hematinics | 3 | 2015 | 276 | 0.530 |
Why?
|
Tetrazoles | 14 | 2022 | 861 | 0.520 |
Why?
|
Troponin T | 5 | 2021 | 751 | 0.500 |
Why?
|
Anemia | 3 | 2015 | 1481 | 0.490 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 11 | 2023 | 1508 | 0.490 |
Why?
|
Echocardiography | 16 | 2023 | 4909 | 0.440 |
Why?
|
Electric Countershock | 1 | 2016 | 523 | 0.440 |
Why?
|
Amlodipine | 1 | 2013 | 80 | 0.440 |
Why?
|
Heart Ventricles | 12 | 2020 | 3772 | 0.430 |
Why?
|
Kidney Failure, Chronic | 6 | 2020 | 2448 | 0.420 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 7 | 2023 | 1068 | 0.410 |
Why?
|
Societies, Medical | 2 | 2021 | 3789 | 0.400 |
Why?
|
Blood Glucose | 3 | 2018 | 6213 | 0.380 |
Why?
|
Positron-Emission Tomography | 12 | 2021 | 6420 | 0.380 |
Why?
|
Fluorodeoxyglucose F18 | 7 | 2019 | 1996 | 0.380 |
Why?
|
Captopril | 6 | 2015 | 266 | 0.380 |
Why?
|
Prognosis | 40 | 2023 | 29068 | 0.380 |
Why?
|
Aged | 81 | 2024 | 164236 | 0.370 |
Why?
|
Calcium Channel Blockers | 1 | 2013 | 688 | 0.350 |
Why?
|
Glomerular Filtration Rate | 4 | 2017 | 2142 | 0.340 |
Why?
|
Valine | 7 | 2008 | 407 | 0.330 |
Why?
|
Heart | 7 | 2023 | 4361 | 0.330 |
Why?
|
Humans | 136 | 2024 | 746044 | 0.330 |
Why?
|
Angiotensin Receptor Antagonists | 3 | 2023 | 962 | 0.310 |
Why?
|
Risk Factors | 38 | 2024 | 72416 | 0.300 |
Why?
|
Male | 98 | 2024 | 351093 | 0.300 |
Why?
|
Spironolactone | 2 | 2023 | 398 | 0.300 |
Why?
|
Diabetes Complications | 6 | 2016 | 1318 | 0.290 |
Why?
|
Heart Rate | 5 | 2018 | 4039 | 0.290 |
Why?
|
Proportional Hazards Models | 23 | 2021 | 12273 | 0.290 |
Why?
|
Female | 100 | 2024 | 382109 | 0.290 |
Why?
|
Echocardiography, Doppler | 7 | 2019 | 898 | 0.280 |
Why?
|
Arrhythmias, Cardiac | 1 | 2016 | 2224 | 0.280 |
Why?
|
Hemoglobins | 1 | 2012 | 1510 | 0.280 |
Why?
|
Benzimidazoles | 6 | 2014 | 857 | 0.270 |
Why?
|
Cardiac Output, Low | 1 | 2006 | 189 | 0.260 |
Why?
|
Outpatients | 1 | 2014 | 1551 | 0.260 |
Why?
|
Fractional Flow Reserve, Myocardial | 2 | 2021 | 327 | 0.260 |
Why?
|
Exercise Tolerance | 4 | 2020 | 788 | 0.260 |
Why?
|
Coronary Disease | 5 | 2019 | 5924 | 0.250 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2023 | 11940 | 0.250 |
Why?
|
Risk Assessment | 18 | 2021 | 23453 | 0.250 |
Why?
|
Middle Aged | 74 | 2024 | 214412 | 0.250 |
Why?
|
Stroke | 8 | 2023 | 9693 | 0.250 |
Why?
|
Aged, 80 and over | 28 | 2024 | 57557 | 0.240 |
Why?
|
Radiopharmaceuticals | 9 | 2020 | 2654 | 0.230 |
Why?
|
Ventricular Dysfunction, Right | 3 | 2023 | 605 | 0.230 |
Why?
|
Technetium Tc 99m Pyrophosphate | 2 | 2020 | 39 | 0.230 |
Why?
|
Pyrans | 1 | 2023 | 50 | 0.230 |
Why?
|
Peptide Fragments | 5 | 2022 | 5032 | 0.220 |
Why?
|
Cardiovascular System | 2 | 2023 | 830 | 0.220 |
Why?
|
Systole | 6 | 2019 | 928 | 0.220 |
Why?
|
Aortic Valve | 2 | 2024 | 1972 | 0.210 |
Why?
|
Inpatients | 1 | 2014 | 2513 | 0.210 |
Why?
|
Leisure Activities | 1 | 2024 | 303 | 0.200 |
Why?
|
Kaplan-Meier Estimate | 7 | 2016 | 6453 | 0.200 |
Why?
|
Predictive Value of Tests | 14 | 2023 | 15009 | 0.200 |
Why?
|
Coronary Circulation | 4 | 2021 | 1559 | 0.200 |
Why?
|
Hypertension | 7 | 2020 | 8358 | 0.200 |
Why?
|
Multivariate Analysis | 8 | 2016 | 12018 | 0.190 |
Why?
|
Myocardial Contraction | 2 | 2018 | 1502 | 0.190 |
Why?
|
Hospitalization | 10 | 2022 | 10329 | 0.190 |
Why?
|
Tellurium | 1 | 2020 | 21 | 0.190 |
Why?
|
Isosorbide Dinitrate | 1 | 2020 | 34 | 0.190 |
Why?
|
Fumarates | 2 | 2011 | 138 | 0.180 |
Why?
|
Troponin | 2 | 2019 | 513 | 0.180 |
Why?
|
Prospective Studies | 21 | 2024 | 53218 | 0.180 |
Why?
|
Heart Atria | 3 | 2022 | 1321 | 0.180 |
Why?
|
Acute Kidney Injury | 2 | 2023 | 1841 | 0.180 |
Why?
|
Tomography, X-Ray Computed | 11 | 2021 | 20142 | 0.170 |
Why?
|
United States | 21 | 2023 | 70383 | 0.170 |
Why?
|
Rubidium Radioisotopes | 3 | 2013 | 78 | 0.170 |
Why?
|
Purines | 2 | 2013 | 590 | 0.170 |
Why?
|
Hypercholesterolemia | 2 | 2018 | 1146 | 0.170 |
Why?
|
Cadmium | 1 | 2020 | 211 | 0.170 |
Why?
|
Feeding Behavior | 1 | 2011 | 3156 | 0.160 |
Why?
|
Renin | 2 | 2011 | 637 | 0.160 |
Why?
|
Radiation Dosage | 2 | 2019 | 1952 | 0.160 |
Why?
|
Dyspnea | 3 | 2023 | 1308 | 0.160 |
Why?
|
Ventricular Function, Right | 5 | 2023 | 595 | 0.160 |
Why?
|
Treatment Outcome | 21 | 2022 | 63661 | 0.160 |
Why?
|
Italy | 1 | 2020 | 824 | 0.160 |
Why?
|
Amides | 2 | 2011 | 455 | 0.160 |
Why?
|
Diastole | 5 | 2023 | 775 | 0.160 |
Why?
|
Coronary Angiography | 5 | 2021 | 4514 | 0.150 |
Why?
|
Follow-Up Studies | 20 | 2019 | 38752 | 0.150 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2023 | 1215 | 0.150 |
Why?
|
Diagnostic Imaging | 3 | 2020 | 3494 | 0.150 |
Why?
|
Cause of Death | 7 | 2017 | 3615 | 0.150 |
Why?
|
Randomized Controlled Trials as Topic | 8 | 2023 | 10094 | 0.140 |
Why?
|
Antihypertensive Agents | 3 | 2006 | 2042 | 0.140 |
Why?
|
Hyperkalemia | 1 | 2018 | 224 | 0.140 |
Why?
|
Obesity | 4 | 2022 | 12670 | 0.140 |
Why?
|
Blood Pressure | 7 | 2020 | 8404 | 0.140 |
Why?
|
Zinc | 1 | 2020 | 683 | 0.130 |
Why?
|
Safety | 1 | 2021 | 1146 | 0.130 |
Why?
|
Health Status Disparities | 2 | 2018 | 1759 | 0.130 |
Why?
|
Defibrillators, Implantable | 2 | 2016 | 1435 | 0.130 |
Why?
|
Smoking | 4 | 2018 | 8975 | 0.130 |
Why?
|
Biphenyl Compounds | 7 | 2022 | 943 | 0.130 |
Why?
|
Calcinosis | 1 | 2024 | 1415 | 0.130 |
Why?
|
Double-Blind Method | 8 | 2018 | 12208 | 0.130 |
Why?
|
Albuminuria | 2 | 2017 | 650 | 0.120 |
Why?
|
Pulmonary Artery | 1 | 2023 | 1919 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 740 | 0.120 |
Why?
|
Heart Valve Diseases | 1 | 2022 | 1034 | 0.120 |
Why?
|
Time Factors | 14 | 2018 | 39587 | 0.120 |
Why?
|
Severity of Illness Index | 6 | 2019 | 15537 | 0.120 |
Why?
|
Survival Rate | 10 | 2022 | 12632 | 0.120 |
Why?
|
Disease Progression | 7 | 2017 | 13303 | 0.120 |
Why?
|
Ankle Brachial Index | 1 | 2014 | 150 | 0.120 |
Why?
|
Survival Analysis | 9 | 2018 | 10127 | 0.120 |
Why?
|
Sex Factors | 7 | 2022 | 10279 | 0.110 |
Why?
|
Tissue Survival | 1 | 2014 | 117 | 0.110 |
Why?
|
Communicable Disease Control | 1 | 2020 | 841 | 0.110 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1377 | 0.110 |
Why?
|
Cardiac Imaging Techniques | 1 | 2016 | 272 | 0.110 |
Why?
|
Amyloidosis | 1 | 2020 | 803 | 0.110 |
Why?
|
Rest | 1 | 2018 | 909 | 0.110 |
Why?
|
Cohort Studies | 16 | 2022 | 40503 | 0.110 |
Why?
|
Creatinine | 2 | 2017 | 1848 | 0.110 |
Why?
|
Mitral Valve | 1 | 2022 | 1458 | 0.110 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2016 | 259 | 0.110 |
Why?
|
Age Factors | 6 | 2018 | 18146 | 0.110 |
Why?
|
Incidence | 10 | 2022 | 20812 | 0.110 |
Why?
|
Risk | 4 | 2021 | 9520 | 0.110 |
Why?
|
Hypotension | 1 | 2018 | 863 | 0.110 |
Why?
|
Adenosine A2 Receptor Agonists | 1 | 2012 | 30 | 0.100 |
Why?
|
Pyrazoles | 2 | 2013 | 1985 | 0.100 |
Why?
|
Frail Elderly | 1 | 2017 | 720 | 0.100 |
Why?
|
Reproducibility of Results | 10 | 2020 | 19804 | 0.100 |
Why?
|
Chi-Square Distribution | 2 | 2016 | 3426 | 0.100 |
Why?
|
Geriatric Assessment | 1 | 2019 | 1367 | 0.100 |
Why?
|
Body Weight | 1 | 2022 | 4590 | 0.100 |
Why?
|
Hyperglycemia | 1 | 2020 | 1353 | 0.100 |
Why?
|
Aortic Valve Stenosis | 1 | 2024 | 2038 | 0.100 |
Why?
|
Radiotherapy | 1 | 2018 | 1504 | 0.090 |
Why?
|
Body Mass Index | 3 | 2022 | 12633 | 0.090 |
Why?
|
Overweight | 1 | 2022 | 2385 | 0.090 |
Why?
|
Weight Loss | 1 | 2022 | 2636 | 0.090 |
Why?
|
Placebos | 3 | 2018 | 1658 | 0.090 |
Why?
|
Heart Transplantation | 3 | 2019 | 3032 | 0.090 |
Why?
|
Proteomics | 1 | 2024 | 3709 | 0.090 |
Why?
|
Prevalence | 6 | 2020 | 15308 | 0.090 |
Why?
|
Adult | 21 | 2024 | 214958 | 0.090 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2011 | 96 | 0.090 |
Why?
|
Heart-Assist Devices | 3 | 2017 | 1244 | 0.090 |
Why?
|
Myocardial Ischemia | 2 | 2014 | 2142 | 0.090 |
Why?
|
alpha-Galactosidase | 1 | 2010 | 54 | 0.090 |
Why?
|
Fasting | 1 | 2016 | 1575 | 0.090 |
Why?
|
Electrocardiography | 6 | 2016 | 6320 | 0.080 |
Why?
|
Stress, Physiological | 2 | 2015 | 1386 | 0.080 |
Why?
|
Coronary Aneurysm | 1 | 2012 | 231 | 0.080 |
Why?
|
Hypertension, Pulmonary | 1 | 2020 | 1541 | 0.080 |
Why?
|
Fabry Disease | 1 | 2010 | 87 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2014 | 3306 | 0.080 |
Why?
|
Death, Sudden, Cardiac | 4 | 2011 | 1529 | 0.080 |
Why?
|
Heart Diseases | 1 | 2022 | 2763 | 0.080 |
Why?
|
Kidney | 3 | 2022 | 6982 | 0.080 |
Why?
|
Retrospective Studies | 11 | 2023 | 78297 | 0.080 |
Why?
|
Myocarditis | 1 | 2016 | 763 | 0.080 |
Why?
|
Atrial Fibrillation | 2 | 2022 | 5050 | 0.080 |
Why?
|
Pneumothorax | 1 | 2011 | 373 | 0.080 |
Why?
|
Hypoglycemic Agents | 2 | 2023 | 3026 | 0.080 |
Why?
|
Cardiotonic Agents | 1 | 2011 | 533 | 0.070 |
Why?
|
Up-Regulation | 1 | 2016 | 4114 | 0.070 |
Why?
|
Patient Selection | 2 | 2016 | 4191 | 0.070 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2008 | 187 | 0.070 |
Why?
|
Ultrasonography | 7 | 2011 | 5899 | 0.070 |
Why?
|
Recovery of Function | 2 | 2016 | 2923 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2020 | 8901 | 0.070 |
Why?
|
Acute Coronary Syndrome | 1 | 2020 | 2334 | 0.070 |
Why?
|
Hemodynamics | 2 | 2014 | 4187 | 0.070 |
Why?
|
Exercise | 2 | 2024 | 5686 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 5 | 2019 | 35784 | 0.070 |
Why?
|
Clinical Trials as Topic | 1 | 2001 | 7935 | 0.070 |
Why?
|
Thiazepines | 1 | 2005 | 31 | 0.070 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2011 | 606 | 0.060 |
Why?
|
Comorbidity | 7 | 2019 | 10351 | 0.060 |
Why?
|
Image Enhancement | 1 | 2016 | 2873 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2015 | 1958 | 0.060 |
Why?
|
Risk Reduction Behavior | 1 | 2011 | 1094 | 0.060 |
Why?
|
Cardiovascular Agents | 1 | 2011 | 847 | 0.060 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2005 | 107 | 0.060 |
Why?
|
Pulmonary Ventilation | 2 | 2017 | 369 | 0.060 |
Why?
|
Linear Models | 1 | 2015 | 5821 | 0.060 |
Why?
|
Myocardium | 2 | 2014 | 4639 | 0.060 |
Why?
|
Bundle-Branch Block | 1 | 2006 | 269 | 0.060 |
Why?
|
Creatine | 1 | 2006 | 414 | 0.060 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2024 | 43 | 0.060 |
Why?
|
Fluoroscopy | 1 | 2008 | 939 | 0.060 |
Why?
|
Endocarditis | 1 | 2008 | 346 | 0.060 |
Why?
|
Glucocorticoids | 1 | 2013 | 2117 | 0.060 |
Why?
|
Ventricular Function | 1 | 2005 | 408 | 0.060 |
Why?
|
Enalapril | 1 | 2005 | 327 | 0.060 |
Why?
|
Proteinuria | 1 | 2006 | 627 | 0.050 |
Why?
|
Neprilysin | 1 | 2005 | 448 | 0.050 |
Why?
|
Heart Defects, Congenital | 1 | 2019 | 4656 | 0.050 |
Why?
|
Sensitivity and Specificity | 5 | 2019 | 14537 | 0.050 |
Why?
|
Depression | 1 | 2021 | 7826 | 0.050 |
Why?
|
Research Design | 3 | 2013 | 6056 | 0.050 |
Why?
|
Protease Inhibitors | 1 | 2005 | 750 | 0.050 |
Why?
|
Cross-Sectional Studies | 3 | 2020 | 25177 | 0.050 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2001 | 132 | 0.050 |
Why?
|
ROC Curve | 3 | 2014 | 3496 | 0.050 |
Why?
|
Hydralazine | 1 | 2020 | 35 | 0.050 |
Why?
|
Aftercare | 2 | 2022 | 892 | 0.050 |
Why?
|
Diphosphates | 1 | 2020 | 84 | 0.050 |
Why?
|
Renal Dialysis | 2 | 2020 | 1691 | 0.050 |
Why?
|
Quality of Life | 1 | 2022 | 12984 | 0.050 |
Why?
|
Oxygen Consumption | 2 | 2017 | 1824 | 0.050 |
Why?
|
Surgery, Computer-Assisted | 1 | 2008 | 1002 | 0.040 |
Why?
|
Postoperative Hemorrhage | 1 | 2023 | 400 | 0.040 |
Why?
|
Longitudinal Studies | 4 | 2021 | 14113 | 0.040 |
Why?
|
Vital Capacity | 1 | 2022 | 952 | 0.040 |
Why?
|
Organ Size | 2 | 2020 | 2239 | 0.040 |
Why?
|
Echocardiography, Doppler, Color | 2 | 2013 | 352 | 0.040 |
Why?
|
Prealbumin | 1 | 2020 | 211 | 0.040 |
Why?
|
Logistic Models | 2 | 2011 | 13164 | 0.040 |
Why?
|
Gynecomastia | 1 | 2018 | 86 | 0.040 |
Why?
|
Hospitals | 2 | 2023 | 3854 | 0.040 |
Why?
|
Kidney Diseases | 2 | 2006 | 2068 | 0.040 |
Why?
|
Massachusetts | 3 | 2015 | 8593 | 0.040 |
Why?
|
Hypolipidemic Agents | 1 | 2002 | 612 | 0.040 |
Why?
|
Renin-Angiotensin System | 1 | 2001 | 741 | 0.040 |
Why?
|
Mitral Valve Insufficiency | 1 | 2007 | 1403 | 0.040 |
Why?
|
Drug Combinations | 1 | 2022 | 1958 | 0.040 |
Why?
|
Mortality | 2 | 2024 | 2852 | 0.030 |
Why?
|
Japan | 1 | 2020 | 1267 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2018 | 5092 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13538 | 0.030 |
Why?
|
Catheter Ablation | 1 | 2008 | 2712 | 0.030 |
Why?
|
Drug Therapy, Combination | 3 | 2015 | 6459 | 0.030 |
Why?
|
Morbidity | 2 | 2012 | 1743 | 0.030 |
Why?
|
Potassium | 1 | 2018 | 1313 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 20750 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2011 | 21673 | 0.030 |
Why?
|
Thrombosis | 1 | 2008 | 2999 | 0.030 |
Why?
|
Aldosterone | 1 | 2018 | 861 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2024 | 2558 | 0.030 |
Why?
|
Radioisotopes | 1 | 2015 | 497 | 0.030 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2014 | 173 | 0.030 |
Why?
|
Pyridines | 1 | 2005 | 2841 | 0.030 |
Why?
|
Carbon Dioxide | 1 | 2017 | 1143 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2015 | 664 | 0.030 |
Why?
|
Quality Control | 1 | 2015 | 819 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2021 | 2370 | 0.030 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2013 | 311 | 0.030 |
Why?
|
Pulmonary Embolism | 1 | 2005 | 2499 | 0.020 |
Why?
|
Recurrence | 3 | 2011 | 8373 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2014 | 15341 | 0.020 |
Why?
|
Lung | 2 | 2022 | 9842 | 0.020 |
Why?
|
Internationality | 2 | 2007 | 979 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2004 | 3960 | 0.020 |
Why?
|
Radiation Protection | 1 | 2015 | 426 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10718 | 0.020 |
Why?
|
Chest Tubes | 1 | 2011 | 143 | 0.020 |
Why?
|
Observer Variation | 2 | 2007 | 2574 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2008 | 6298 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2008 | 5261 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2021 | 3073 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2004 | 3331 | 0.020 |
Why?
|
Patient Discharge | 1 | 2022 | 3311 | 0.020 |
Why?
|
Probability | 2 | 2005 | 2468 | 0.020 |
Why?
|
Wounds, Penetrating | 1 | 2011 | 301 | 0.020 |
Why?
|
Multicenter Studies as Topic | 2 | 2004 | 1679 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6781 | 0.020 |
Why?
|
Neoplasms | 1 | 2018 | 21688 | 0.020 |
Why?
|
Perfusion | 1 | 2013 | 1337 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2011 | 453 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 2013 | 961 | 0.020 |
Why?
|
Chest Pain | 1 | 2016 | 1093 | 0.020 |
Why?
|
Calcium | 1 | 2021 | 5654 | 0.020 |
Why?
|
Thorax | 1 | 2011 | 543 | 0.020 |
Why?
|
Carotid Artery Diseases | 1 | 2014 | 862 | 0.020 |
Why?
|
Databases, Factual | 1 | 2023 | 7810 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8370 | 0.020 |
Why?
|
Area Under Curve | 1 | 2011 | 1601 | 0.020 |
Why?
|
Public Health | 1 | 2020 | 2624 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9596 | 0.020 |
Why?
|
Lipids | 1 | 2018 | 3290 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9209 | 0.020 |
Why?
|
Survivors | 2 | 2008 | 2302 | 0.020 |
Why?
|
Cardiac Volume | 1 | 2007 | 200 | 0.020 |
Why?
|
Death, Sudden | 1 | 2008 | 303 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2012 | 2339 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2008 | 847 | 0.020 |
Why?
|
Chronic Disease | 2 | 2014 | 9116 | 0.020 |
Why?
|
Wounds, Nonpenetrating | 1 | 2011 | 796 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2011 | 1273 | 0.020 |
Why?
|
Tachycardia, Ventricular | 1 | 2013 | 1285 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2013 | 1867 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2011 | 974 | 0.010 |
Why?
|
Contrast Media | 1 | 2018 | 5253 | 0.010 |
Why?
|
Biopsy | 1 | 2016 | 6732 | 0.010 |
Why?
|
Life Tables | 1 | 2004 | 368 | 0.010 |
Why?
|
Atrial Natriuretic Factor | 1 | 2005 | 378 | 0.010 |
Why?
|
Tricuspid Valve | 1 | 2007 | 402 | 0.010 |
Why?
|
Heart Function Tests | 1 | 2004 | 317 | 0.010 |
Why?
|
Tomography, Spiral Computed | 1 | 2005 | 268 | 0.010 |
Why?
|
Young Adult | 3 | 2019 | 57106 | 0.010 |
Why?
|
Pulmonary Veins | 1 | 2008 | 732 | 0.010 |
Why?
|
Adolescent | 3 | 2019 | 86202 | 0.010 |
Why?
|
Europe | 1 | 2008 | 3354 | 0.010 |
Why?
|
Sweden | 1 | 2004 | 1367 | 0.010 |
Why?
|
Software | 1 | 2015 | 4399 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2004 | 1563 | 0.010 |
Why?
|
Canada | 1 | 2004 | 2088 | 0.010 |
Why?
|
Registries | 1 | 2015 | 8170 | 0.010 |
Why?
|
Medical Records | 1 | 2004 | 1390 | 0.010 |
Why?
|
Reference Values | 1 | 2004 | 4875 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 41376 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2004 | 4858 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2004 | 6220 | 0.010 |
Why?
|
Acute Disease | 1 | 2005 | 7116 | 0.010 |
Why?
|
Inflammation | 1 | 2013 | 10592 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12839 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2011 | 7699 | 0.010 |
Why?
|
Child | 1 | 2019 | 78456 | 0.010 |
Why?
|
Insulin | 1 | 2004 | 6470 | 0.010 |
Why?
|